DSP Nifty Healthcare ETF
Direct · Growth ₹16.63
18 Aug 2026
NAV
0.2%
Weighted CAGR
?
Weighted Mean CAGR
Gives more importance to longer time periods (10Y, 20Y) than shorter ones (1Y, 3Y). This balances out recent outperformance and gives a more realistic picture of what long-term returns might look like.
Gives more importance to longer time periods (10Y, 20Y) than shorter ones (1Y, 3Y). This balances out recent outperformance and gives a more realistic picture of what long-term returns might look like.
-0.23
Sharpe
-90.0%
Max Drawdown
?
Max Drawdown
The largest peak-to-trough decline in the fund's NAV. Shows the worst-case loss an investor would have experienced at any point in the fund's history.
The largest peak-to-trough decline in the fund's NAV. Shows the worst-case loss an investor would have experienced at any point in the fund's history.
0.20%
TER
If you invested ₹1,00,000 every month via SIP, here's how this fund has historically performed across different time horizons.
| Duration | Invested | Median Value | XIRR | Min XIRR | Max XIRR |
|---|---|---|---|---|---|
| 1 Year | ₹12.00 L | ₹12.34 L | -2.0% | -99.9% | 35.3% |
SIP returns vs benchmark & category
Annualised SIP return (XIRR) over each rolling horizon — like-for-like, not lump-sum.
| Duration | Fund SIP XIRR | Category avg |
|---|---|---|
| 1 Year | -2.0% | 14.0% |
| Duration | Mean | Median | Min | Max | Sharpe | Sortino | % Positive | Cat. Mean | Cat. Median |
|---|---|---|---|---|---|---|---|---|---|
| 1 Year | 0.2% | 7.7% | -88.9% | 23.8% | -0.23 | -0.22 | 85% | — | — |
-90.0%
Max Drawdown
0 mo
Drawdown Duration
Not recovered
Recovery Time
-8.0%
Avg Drawdown
Calmar Ratio by Duration
0.00
1Y
19
Total Holdings
77.3%
Top 10 Weight
2
Sectors
| # | Stock | % of NAV |
|---|---|---|
| 1 | Sun Pharmaceutical Industries Limited | 18.07% |
| 2 | Divi's Laboratories Limited | 10.34% |
| 3 | Apollo Hospitals Enterprise Limited | 7.87% |
| 4 | Cipla Limited | 6.82% |
| 5 | Max Healthcare Institute Limited | 6.67% |
| 6 | Laurus Labs Limited | 6.41% |
| 7 | Torrent Pharmaceuticals Limited | 6.39% |
| 8 | Dr. Reddy's Laboratories Limited | 6.05% |
| 9 | Lupin Limited | 4.57% |
| 10 | Aurobindo Pharma Limited | 4.09% |